ArticleFrontiers in medicine2025
A six-gene expression signature in peripheral blood mononuclear cells effectively diagnoses osteoarthritis.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- COLGALT2 Polymorphisms are Associated with Osteoarthritis Risk and Clinical Severity in a Chinese Population.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Osteoarthritis (OA) is a heterogeneous whole-joint disease that inconveniences more than 500 million people worldwide. Early diagnostic methods for OA remain lacking. Peripheral blood mononuclear cells (PBMCs) are ideal sample sources for the early diagnosis of different diseases. However, only a few studies have reported on the role of PBMCs in the early diagnosis of OA. Methods: RNA sequencing was performed on PBMC samples from 27 patients with OA and 31 healthy controls. We integrated RNA sequencing data from our internal cohort and microarray data from external cohort to construct a diagnostic model of OA based on PBMC samples. The receiver operating characteristic (ROC) curve analysis was used to evaluate the diagnostic model in PBMC samples and synovial tissue. Results: In this study, we screened and constructed a six-gene diagnostic model consisted of the genes THBS1, USP36, GIMAP4, OSM, IL10, and HDC, which could effectively distinguish patients with OA from healthy controls. The ROC curve analysis showed that the area under curve (AUC) of this diagnostic model was 0.928 for our internal cohort and 0.915 for the external cohort, respectively. Interestingly, the gene expression model also had high accuracy (AUC = 0.910) for diagnosing patients with OA based on expression data from synovial tissue. Discussion: Given that related studies on several signature genes in our diagnostic model for OA are lacking, our study provides novel potential biomarkers for the early diagnosis of OA based on PBMC samples.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.